Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases. Founded by James Mackay in 2018, Aristea Therapeutics is backed by Fidelity Management and Research Company, Arena Pharmaceuticals, Novo Holdings, and Tekla Capital Management and is headquartered in San Diego.
FOUNDED:
2018
INDUSTRY:
Biotechnology, Medical, Pharmaceutical
FOUNDERS:
James Mackay
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
